JM

John Mauldin

North America, Texas, United States, Dallas

Description

John Mauldin is a renowned financial expert and New York Times best-selling author whose newsletter has over 1 million readers. Mr. Mauldin ...

Investor Profile

John Mauldin has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series Unknown rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Therapeutics.

Stage Focus

  • Series Unknown (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does John Mauldin frequently co-invest with?

IC
North America, Massachusetts, United States, Boston
Co-Investments: 1
Lineage Cell Therapeutics
North America, California, United States, Carlsbad
Co-Investments: 1
KIZOO Technology Capital
Europe, Baden-Wurttemberg, Germany, Karlsruhe
Co-Investments: 1

Which angels does John Mauldin often collaborate with?

JM
Europe, Isle of Man
Shared Deals: 1
Shared Deals: 1

What are some of recent deals done by John Mauldin?

AgeX Therapeutics

Alameda, California, United States

AgeX is a biotechnology company that develops novel therapeutics for age-related degenerative diseases.

BiotechnologyHealth CareTherapeutics
Series UnknownAug 2, 2017
Amount Raised: $10,000,000